These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7839357)

  • 1. The relationship between the concentration of the pyrrolizidine alkaloid monocrotaline and the pattern of metabolites released from the isolated liver.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):1-8. PubMed ID: 7839357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between glutathione concentration and metabolism of the pyrrolizidine alkaloid, monocrotaline, in the isolated, perfused liver.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):132-9. PubMed ID: 7839360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of the hepatic release of metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1994 Jul; 127(1):58-63. PubMed ID: 8048054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver.
    Yan CC; Cooper RA; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Aug; 133(2):277-84. PubMed ID: 7645024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic glutathione concentrations and the release of pyrrolic metabolites of the pyrrolizidine alkaloid, monocrotaline, from the isolated perfused liver.
    Nigra L; Huxtable RJ
    Toxicon; 1992 Oct; 30(10):1195-202. PubMed ID: 1440625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary excretion of pyrrolic metabolites of [14C]monocrotaline in the rat.
    Lamé MW; Jones AD; Morin D; Segall HJ; Wilson DW
    Drug Metab Dispos; 1995 Mar; 23(3):422-9. PubMed ID: 7628310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of [14C]monocrotaline by isolated perfused rat liver.
    Lamé MW; Jones AD; Morin D; Segall HJ
    Drug Metab Dispos; 1991; 19(2):516-24. PubMed ID: 1676664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine.
    Pan LC; Wilson DW; Lamé MW; Jones AD; Segall HJ
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):87-97. PubMed ID: 8430429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo.
    Wang YP; Yan J; Beger RD; Fu PP; Chou MW
    Cancer Lett; 2005 Aug; 226(1):27-35. PubMed ID: 16004930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliary excretion of novel pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Lafranconi WM; Ohkuma S; Huxtable RJ
    Toxicon; 1985; 23(6):983-92. PubMed ID: 3938082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of an alkylating metabolite, dehydromonocrotaline, from the isolated liver perfused with the pyrrolizidine alkaloid, monocrotaline.
    Yan CC; Huxtable RJ
    Proc West Pharmacol Soc; 1994; 37():107-8. PubMed ID: 7984635
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of monocrotaline metabolites on glutathione levels in human and bovine pulmonary artery endothelial cells.
    Reid MJ; Dunston SK; Lamé MW; Wilson DW; Morin D; Segall HJ
    Res Commun Mol Pathol Pharmacol; 1998 Jan; 99(1):53-68. PubMed ID: 9523355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a reactive pyrrole in the hepatic metabolism of the pyrrolizidine alkaloid, monocrotaline.
    Glowaz SL; Michnika M; Huxtable RJ
    Toxicol Appl Pharmacol; 1992 Aug; 115(2):168-73. PubMed ID: 1641851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
    Yan J; Xia Q; Chou MW; Fu PP
    Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid.
    Chou MW; Jian Y; Williams LD; Xia Q; Churchwell M; Doerge DR; Fu PP
    Chem Res Toxicol; 2003 Sep; 16(9):1130-7. PubMed ID: 12971801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver.
    Williams DE; Reed RL; Kedzierski B; Dannan GA; Guengerich FP; Buhler DR
    Drug Metab Dispos; 1989; 17(4):387-92. PubMed ID: 2571477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine.
    Xia Q; Yan J; Chou MW; Fu PP
    Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 9-Glutathionyl-6,7-dihydro-1-hydroxymethyl-5H-pyrrolizine Is the Major Pyrrolic Glutathione Conjugate of Retronecine-Type Pyrrolizidine Alkaloids in Liver Microsomes and in Rats.
    Chen M; Li L; Zhong D; Shen S; Zheng J; Chen X
    Chem Res Toxicol; 2016 Feb; 29(2):180-9. PubMed ID: 26761523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the pyrrolizidine alkaloid, monocrotaline, on bile composition of the isolated, perfused rat liver.
    Yan CC; Huxtable RJ
    Life Sci; 1995; 57(6):617-26. PubMed ID: 7623629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.